The upcoming low-dose lithium trial, scheduled for March 2026, aims to explore its effects on Alzheimer's disease, a growing concern in aging populations.
Initial results from similar studies have indicated promising outcomes, suggesting that lithium could play a role in the prevention of Alzheimer's.
This research could lead to innovative treatment options that are both effective and affordable, impacting the overall approach to Alzheimer’s care.